Associated Papers
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.
Brown JR et al.
Blood, 2026
41055698 (PubMed )
Supplement: BLOOD_BLD-2024-027009-mmc5.xlsx › Sheet_1
Melanoma-associated mutants within the serine-rich domain of PAK5 direct kinase activity to mitogenic pathways.
LaPak KM et al.
Oncotarget, 2018
Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS.
Kim JE et al.
Translational Oncology, 2018
Select a paper to view details